Qingsong Capital

Meichuang Medical is an innovative medical device company that focuses on the R&D, manufacturing and commercialization of high-end medical devices in the fields of peripheral vascular intervention, tumor intervention, and hemodialysis access maintenance

Oukejian specializes in researching and developing innovative large-molecule drugs for prevalent fundus diseases.

Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development.

Worg Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative treatments for allergies and other diseases with significant unmet medical needs. The company is constructing a robust pipeline targeting allergy and autoimmune disorders through two technology platforms, PCFiT and Apitope, leveraging both internal development and strategic collaborations. Additionally, Worg is advancing a platform for molecular allergy diagnosis, enhancing its capabilities in addressing allergy-related health issues. Through its flexible business models, Worg Pharmaceuticals aims to accelerate the development of effective immunotherapies and contribute to improved patient outcomes in the field of allergy and autoimmune diseases.

Weixu Biotechnology is a livestock biotechnology business that produces and markets animal serum, animal blood products, and biological raw materials. It also offers sales and technical services for animal products, feed additives, microbiological preparations, animal nutritional health products, and feed raw materials.

Meson Technology is a provider of chemical technology services specializing in the deployment of continuous-flow chemical technology systems. Its operations include continuous manufacturing methods for fine chemicals and biopharmaceutical goods, as well as continuous environmental protection treatment.

Cornerstone Robotics operates to improve the accessibility of high-end medical services in China.

Meichuang Medical is an innovative medical device company that focuses on the R&D, manufacturing and commercialization of high-end medical devices in the fields of peripheral vascular intervention, tumor intervention, and hemodialysis access maintenance

Bio-Engine is a developer of high-density serum-free suspension culture technology for animal cells. Its main products include HEK293 cell serum-free medium, PK15 cell serum-free medium, etc., which can be applied to antibodies, recombinant proteins, human and livestock. Virus vaccine, cell therapy and other fields.

Ouli Biomedical is a pharmaceutical company. They offer nucleic acid drug discovery, laboratory research and development, process and analysis development, CMC services, API production, and drug registration.

Cospowers is a technology-driven company that specializes in developing and manufacturing smart lithium battery solutions for a global clientele. Established in 2003, the company focuses on providing a one-stop comprehensive energy storage solution, which includes rechargeable batteries, chargers, and power battery packs. Cospowers employs advanced technology and scientific management methods to ensure product safety and reliability. Their offerings cater to various applications, including network energy, electric energy storage, and consumer batteries, promoting clean and efficient energy solutions. The products are well-received by customers, reflecting the company's commitment to quality and innovation in the energy storage sector.

CATUG Biotechnology specializes in the development and application of advanced biomedical technologies, particularly in the fields of gene therapy and nucleic acid drugs. The company offers comprehensive contract development and manufacturing organization (CDMO) services, addressing the entire industry chain from research and development to clinical applications and industrialization. CATUG operates R&D centers and industrialization bases located in Suzhou and Wuhan, facilitating its focus on drug research and production services.

Ionova Life Science is an anti-tumor drug developer dedicated to the development of innovative types of tumor-targeted drugs and tumor immunomodulatory drugs, including oncology, immuno-oncology, and cardiac metabolic diseases. Force contact

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science. The company currently has more than a dozen of independently-developed mRNA drug projects, focusing on the fields of mRNA-based personalized cancer vaccines, mRNA vaccines for infectious disease, protein defects diseases, and genetic diseases, providing cure and solutions for cancer and infectious diseases, better serving patients.

LaNova Medicines is a clinical-stage innovative drug research and development company. The company focuses on the unmet therapeutic needs in the field of tumor immunity and tumor microenvironment and focuses on the research and development of "world's first" and "best-in-class" potential bio-innovative drugs.

MEDx provides precision medicine solutions to improve clinical development. Its services use translational science for diagnostic technology of nucleic acid and protein. It also offers biomarker development, Companion Diagnostics (CDx), Point-of-Care (POC) development, clinical testing, and commercialization. The company was founded in 2013 and is headquartered in Suzhou, Jiangsu.